BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29288096)

  • 1. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer.
    Rogers EM; Connolly KL; Nehal KS; Dusza SW; Rossi AM; Lee E
    J Am Acad Dermatol; 2018 Jun; 78(6):1119-1124. PubMed ID: 29288096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?
    Linos E; Chren MM; Stijacic Cenzer I; Covinsky KE
    J Am Geriatr Soc; 2016 Aug; 64(8):1610-5. PubMed ID: 27303932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy after Mohs micrographic surgery in patients aged 90 years and older.
    Delaney A; Shimizu I; Goldberg LH; MacFarlane DF
    J Am Acad Dermatol; 2013 Feb; 68(2):296-300. PubMed ID: 23200199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
    Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
    J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
    [No Abstract]   [Full Text] [Related]  

  • 5. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical re-evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults: Should we waive this treatment in certain patients?
    Van Coile L; Brochez L; Verhaeghe E; Boone B; Meertens A; Ongenae K; Hoorens I
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1792-1798. PubMed ID: 37147863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
    Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
    Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
    Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
    Schinstine M; Goldman GD
    J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
    Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
    JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.
    Shelton ME; Adamson AS
    Dermatol Clin; 2019 Oct; 37(4):425-433. PubMed ID: 31466583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
    Lane JE; Kent DE
    Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
    Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
    J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: implications for selecting surgical candidates.
    Charles AJ; Otley CC; Pond GR
    J Am Acad Dermatol; 2002 Sep; 47(3):419-22. PubMed ID: 12196753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
    Schell AE; Russell MA; Park SS
    JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
    Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Topographical Mohs Micrographic Surgery Maps for Rapid Review of Clinicopathologic Characteristics of Nonmelanoma Skin Cancers of the Ear.
    Tolkachjov SN
    Dermatol Surg; 2018 Jan; 44(1):25-30. PubMed ID: 28858932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
    Zabielinski M; Leithauser L; Godsey T; Gloster HM
    Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
    Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
    Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.